I am with you, Pete. These things take lots of time with biopharma, more than you think or would seem "normal" in a business sense. Guess it's not like developing a technology or product and bringing it to market when you have FDA, etc. Guess that is a good thing, they protect us from a lot of bad drugs, etc. Hopefully, with some of the new "break through" and orphan drug streamlining CTIX can get to the finish line faster than we could have thought possible even a year or two ago. The best is yet to come.... keep the faith!